undamentalytics Newsletter
Sign in

Camp4 Therapeutics Corp revenue

Camp4 Therapeutics Corp's revenue was $3.5m in fiscal 2025, up 436.5% on the year before. Over the last twelve months it was $4.2m.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue3506523,4984,216
Growth on the year before—+86.3%+436.5%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Camp4 Therapeutics Corp $4.2m 40.2% —
Curis Inc $4.3m -62.2% -25.0%
Ensysce Biosciences, Inc. $4.5m -39.3% 14.6%
Ocugen, Inc. $4.6m -3.7% 26.3%
DBV Technologies S.a. $3.8m -31.6% -11.6%
Dyadic International Inc $3.8m -8.0% 3.4%

Compare with peers

Head to head: CAMP vs CRISCAMP vs ENSCCAMP vs OCGNCAMP vs DBVT

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Camp4 Therapeutics Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Camp4 Therapeutics Corp.